Shell Asset Management CO Inovio Pharmaceuticals, Inc. Transaction History

Shell Asset Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $130,012 - $314,334	164,573 New	164,573 $135,000
Q2 2022 Aug 09, 2022	SELL	$1.44 - $3.98 $13,531 - $37,400	-9,397 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$2.97 - $5.2 $4,208 - $7,368	-1,417 Reduced 13.1%	9,397 $34,000
Q4 2021 Feb 09, 2022	SELL	$4.99 - $7.46 $883 - $1,320	-177 Reduced 1.61%	10,814 $54,000
Q3 2021 Nov 04, 2021	SELL	$7.16 - $9.69 $3,078 - $4,166	-430 Reduced 3.76%	10,991 $79,000
Q1 2021 May 10, 2021	SELL	$8.81 - $16.96 $18,624 - $35,853	-2,114 Reduced 15.62%	11,421 $106,000
Q2 2020 Aug 10, 2020	BUY	$7.14 - $31.69 $96,639 - $428,924	13,535 New	13,535 $365,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.